Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Biotech Remove


July 2019
WeTuMoSuSaFrTh
17161514131211

Public Company News

Business Press Releases

Biotech Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By ResoTher Pharma ApS
A Danish biotech believe they have a novel therapy that will protect the heart in the critical days after myocardial infarction, reducing heart failure and improving patient´s lives.
12762590
By ReStem Biotech
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, spinal cord injury and cancer, sponsored the Guangdong Private..
By Golden Helix
Automated and Guided Workflows for Clinical Testing Using NGS Assays
By LGM Pharma
Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, LLC, a leader in API sourcing, warehousing and distribution services to the pharmaceutical and...
By European Society of Cardiology
Don't ignore heart attack symptoms while traveling, keep emergency numbers at hand.That's the main message of a new study. Cardiovascular disease is the leading cause of natural death among people who are traveling, yet, so far, the long-term outlook
By Neurolixis, Inc.
A new article in the Journal of Medicinal Chemistry describes the characterization of novel selective serotonin 5-HT1A receptor biased agonists.
12752677
By S-cubed
S-cubed is pleased to announce that after a rigorous evaluation process, the Qlik development team have been awarded Specialization Status in the Pharmaceutical and Biotech Industries.
By Bioquark Inc.
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe.
12746260
By TRIGR Therapeutics
TRIGR Therapeutics, Inc. ("TRIGR"), a privately held biotechnology company focused on the clinical development and commercialization of bispecific antibody therapeutics for oncology and ophthalmology indications, announced that it will present at Biotech.
By Novodiax
Novodiax Inc., a leader in intraoperative immunohistochemistry (IHC) technology, announces the availability of two new ihcDirect staining kits for in vitro diagnostic (IVD) use: CD20 and Vimentin.
12744713
By AmerAsia Report
AmerAsia Report, a leading provider of education and information across the America's and Asia, today published an update to an astounding year's long precedent of getting trapped inside the honey pot.
12740227
By Stemology®
Ever Innovating, Stemology® Announces the Release of SRC-7™, Its Patent-Pending Advanced Stem Cell Technology Complex
12738941
By Keystone Symposia
Keystone Symposia, in partnership with Vienna BioCenter Research Institutes GMI, IMBA, IMP and MFPL, is pleased to announce a series of scientific research conferences to be held at Vienna BioCenter in Vienna, Austria.
12735061
By R3eWaste, Sonora Quest Laboratories
Two Phoenix-based companies working together to help each other and the environment.
By Partners4Access
Sophie Schmitz, Managing Partner of Partners4Access is to chair a panel discussion on rare diseases at the BioIndustry Association or BIA's event UK Bioscience Forum on October 18, 2018.
By Wareham Development
Newly Constructed Research Campus in Emeryville, Now Leasing
By Golden Helix, Inc.
Integrating CNV analysis into a NextGen sequencing clinical analytics platform
By Pharma Market Research Conference
Switzerland will host anticipated assembly of market research influencers
By PR&D
·      New combination reduces blocked nose without a pharmaceutical ingredient while simultaneously combating viral airway infections ·      Patent application submitted for innovative formulation Vienna, 7 August 2018.
By RGR Medical Products Inc
David Carter was hired as Vice President of retail accounts for RGR medical and in charge of promoting SleepEeze. Carter a 20 year veteran of retail sales, comes to RGR Medical from the successful sale of his own private business in 2016
By iHEAR® Medical
Public can now walk into their pharmacy and purchase the iHEARTEST™Kit to evaluate their hearing at home
By RGR Medical Products
RGR Medical Products Inc. has moved into its new facility located in Fishers, Indiana at 11807 Allisonville Road. RGR Medical has "outgrown" its previous office location at 11805 Pennsylvania Avenue in Carmel, Indiana.
By DevonMD
New partnership expands Devon MD's product footprint and global growth strategy
By Pharma Market Research Conference
Annual market research event starts next week in South San Francisco
By Ronald Reed CEO
Mr. Greg Hughes has been named today, National Sales Director of RGR Medical Porducts replacing William Mastro who is retiring. Mr. Hughes is a 20+ year pharmaceutical industry veteran.
By Pharma Market Research Conference
Register before May 25 to get the best price for returning West Coast event
By RGR Medical Products Inc.
RGR Medical Products has begun the the initial stage of a private placement memorandum to raise capital for its new sleeping aid product SleepEEZE. SleepEEZE is a patent pending over the counter supplement supporting sleep.
By LGM Pharma
LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr.
12707107
By Rubix LS
Rubix LS is announcing today the launch of it's new Data & Research division to its core business function.  This is a step for Rubix LS to strongly position its expertise base to move as a technological think tank.
By RGR Medical Products
RGR Medical products as entered into an exclusive agreement to distribute NeuroZen Rehabilitation Technologies two new diabetic neurological pain management products.
By Partners4Access
PARTNERS4ACCESS has announced the appointment of Alison Kneen as Vice President of International Operations to lead its rapidly expanding Market Access Orphan Drug Specialist team.

Page: 1 2 Next Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share